Rasburicase: A Review of its Use in the Management of Anticancer Therapy-Induced Hyperuricaemia

Author： Oldfield Vicki   Perry Caroline M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.4, 2006-01, pp. : 529-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticancer therapy-induced adverse events: practicing damage control

By Lacouture Mario E   Lenihan Daniel   Wu Shenhong  

Expert Opinion on Drug Safety, Vol. 11, Iss. 1, 2012-05 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Febuxostat: a guide to its use in chronic hyperuricaemia

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 2, 2009-02 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Aliskiren: A Review of its Use as Monotherapy and as Combination Therapy in the Management of Hypertension

By Duggan Sean T.   Chwieduk Claudine M.   Curran Monique P.  

Drugs, Vol. 70, Iss. 15, 2010-10 ,pp. : 2011-2049

Adis International

Access to resources Recommend Favorite

Argatroban: A Review of its Use in the Management of Heparin-Induced Thrombocytopenia

By Dhillon Sohita  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 261-282

Adis International

Access to resources Recommend Favorite

Fosamprenavir: A Review of its Use in the Management of Antiretroviral Therapy-Naive Patients with HIV Infection

By Therese M. Chapman   Greg L. Plosker   Caroline M. Perry  

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2101-2124

Adis International

Access to resources Recommend Favorite